Benitec Biopharma Inc (BNTC)
8.63
+0.40
(+4.86%)
USD |
NASDAQ |
May 08, 16:00
8.63
0.00 (0.00%)
After-Hours: 17:17
Benitec Biopharma Enterprise Value: 0.9615M for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 0.9615M |
| May 06, 2024 | 1.195M |
| May 03, 2024 | 2.828M |
| May 02, 2024 | 2.617M |
| May 01, 2024 | 0.106M |
| April 30, 2024 | 1.532M |
| April 29, 2024 | -1.112M |
| April 26, 2024 | -2.486M |
| April 25, 2024 | -2.383M |
| April 24, 2024 | -2.953M |
| April 23, 2024 | -2.590M |
| April 22, 2024 | -2.953M |
| April 19, 2024 | -2.253M |
| April 18, 2024 | -2.694M |
| April 17, 2024 | -7.930M |
| April 16, 2024 | -7.982M |
| April 15, 2024 | -7.645M |
| April 12, 2024 | -6.116M |
| April 11, 2024 | -4.223M |
| April 10, 2024 | -4.846M |
| April 09, 2024 | -5.075M |
| April 08, 2024 | -5.701M |
| April 05, 2024 | -5.934M |
| April 04, 2024 | -5.857M |
| April 03, 2024 | -6.012M |
| Date | Value |
|---|---|
| April 02, 2024 | -6.634M |
| April 01, 2024 | -7.153M |
| March 28, 2024 | -6.764M |
| March 27, 2024 | -7.075M |
| March 26, 2024 | -7.516M |
| March 25, 2024 | -7.516M |
| March 22, 2024 | -7.542M |
| March 21, 2024 | -7.179M |
| March 20, 2024 | -6.505M |
| March 19, 2024 | -7.230M |
| March 18, 2024 | -7.049M |
| March 15, 2024 | -7.153M |
| March 14, 2024 | -6.971M |
| March 13, 2024 | -6.919M |
| March 12, 2024 | -7.451M |
| March 11, 2024 | -7.516M |
| March 08, 2024 | -7.697M |
| March 07, 2024 | -7.594M |
| March 06, 2024 | -6.868M |
| March 05, 2024 | -6.556M |
| March 04, 2024 | -8.086M |
| March 01, 2024 | -5.805M |
| February 29, 2024 | -7.801M |
| February 28, 2024 | -8.708M |
| February 27, 2024 | -8.967M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-18.58M
Minimum
Dec 05 2023
414.08M
Maximum
May 15 2019
35.50M
Average
5.033M
Median
Enterprise Value Benchmarks
| Galectin Therapeutics Inc | 255.68M |
| TG Therapeutics Inc | 2.444B |
| BioVie Inc | 9.406M |
| Jaguar Health Inc | 114.89M |
| First Wave BioPharma Inc | 2.248M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.798M |
| Total Expenses (Quarterly) | 6.927M |
| EPS Diluted (Quarterly) | -2.64 |
| Earnings Yield | -126.9% |
| Normalized Earnings Yield | -186.98 |